Back to Peptipedia
MetabolismHuman research

Cagrilintide

Cagrilintide is a long-acting amylin analogue studied in obesity.

Peptipedia explains research and prescribing information. It does not replace medical advice and is not an invitation to use a substance.

Research areas

Source-based short profile

Evidence matrix

Molecular identity
Confirmed

Cagrilintide is a defined long-acting amylin analogue. The trial product is not interchangeable with an arbitrary unspecified combination.

Human research
Moderate
Replication
Single research group
Clinical endpoints
Symptom- or function-related
Safety
Limited characterization
Approval
No documented approval

The dimensions are presented separately and are not combined into an overall score.

What the source shows

REDEFINE 1 compared coadministration with semaglutide against the individual agents and placebo.

Research gaps

  • ·Results for a defined trial product do not automatically apply to arbitrary blends.
  • ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.